Golden Square

Golden Square Lab is an Indian specialty pharmaceutical company focused on the urology market. The company states that it was incorporated in December 2022 and is building a branded product portfolio aimed at Indian urologists, with specialties including benign prostatic hyperplasia, overactive bladder, urinary tract infection, renal stones, and male infertility. Publicly visible evidence indicates that its business is centered on marketed prescription products rather than novel R&D-stage therapeutics, with products listed through Indian pharmacy marketplaces. Based on the available information, Golden Square Lab appears to operate as a small, private, early-stage commercial pharma company in India rather than a venture-backed biotech developer.